Eli Lilly

Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals
Endpoints
Mon, 10/12/20 - 10:28 am
Eli Lilly
mirikizumab
Crohn's Disease
clinical trials
Eli Lilly, Gates Foundation to supply COVID-19 antibody drug to low-income countries
Beckers Hospital Review
Sat, 10/10/20 - 11:30 pm
Eli Lilly
Gates Foundation
COVID-19
antibodies
pandemic
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Pharmaforum
Fri, 10/9/20 - 10:52 am
Eli Lilly
olumiant
baricitinib
Gilead Sciences
Veklury
remdesivir
COVID-19
clinical trials
NIH
Pfizer-Lilly Endeavor Shows NGF Inhibitor Tanezumab Lowers Osteoarthritic Pain
BioSpace
Thu, 10/8/20 - 11:29 pm
Pfizer
Eli Lilly
tanezumab
BLA
osteoarthritis
Eli Lilly rushes to FDA with its COVID-19 antibody for emergency green light, reveals new cocktail therapy data
Fierce Biotech
Wed, 10/7/20 - 10:58 am
Eli Lilly
FDA
COVID-19
antibodies
Fourth-quarter events to watch for big pharma
EP Vantage
Mon, 09/28/20 - 10:34 pm
COVID-19
clinical trials
AstraZeneca
Gilead Sciences
Takeda
GSK
Roche
Alzheimer's disease
Bristol-Myers Squibb
Pfizer
Eli Lilly
HHS general counsel scolds Eli Lilly for halting 340B drug discounts
Beckers Hospital Review
Thu, 09/24/20 - 10:30 am
HHS
Eli Lilly
340B
hospitals
discounts
ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer
Fierce Pharma
Sun, 09/20/20 - 07:54 pm
Ibrance
Pfizer
Eli Lilly
Verzenio
breast cancer
ESMO
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Fierce Pharma
Thu, 09/17/20 - 10:56 am
Eli Lilly
Amgen
LY-CoV-55
antibody cocktail
COVID-19
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
MedCity News
Wed, 09/16/20 - 07:47 pm
Eli Lilly
olumiant
Gilead Sciences
remdesivir
Veklury
drug pricing
COVID-19
Lilly offers first evidence that its antibody drug may help treat COVID-19
BioPharma Dive
Wed, 09/16/20 - 10:59 am
Eli Lilly
AbCellera
antibodies
COVID-19
clinical trial
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Marketwatch
Mon, 09/14/20 - 10:21 am
Eli Lilly
Incyte
olumiant
COVID-19
remdesivir
Gilead Sciences
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Fierce Pharma
Fri, 09/11/20 - 12:11 pm
Eli Lilly
migraines
clinical trials
Reyvow
Biohaven
AbbVie
Eli Lilly stops giving 340B discounts to contract pharmacies
Beckers Hospital Review
Thu, 09/3/20 - 11:56 pm
Eli Lilly
340B
contract pharmacies
hospitals
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
EP Vantage
Mon, 08/31/20 - 10:13 am
ESC
Eli Lilly
Boehringer Ingelheim
Farxiga
Jardiance
heart failure
AstraZeneca
Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi
Endpoints
Fri, 08/21/20 - 12:45 pm
Eli Lilly
Lilly Asia Ventures
AstraZeneca
China
R&D
Dizal Pharmaceutical
Eli Lilly Strikes $1 Billion Deal with Innovent for Checkpoint Inhibitor
BioSpace
Tue, 08/18/20 - 11:00 pm
Eli Lilly
Innovent Biologics
China
immuno-oncology
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?
Motley Fool
Sun, 08/16/20 - 10:40 pm
artificial intelligence
drug development
AstraZeneca
GSK
Novartis
Eli Lilly
Five Top Drugmakers Reveal List vs. Net Price Gaps
Drug Channels
Tue, 08/11/20 - 01:17 pm
Eli Lilly
Janssen
Merck
Novartis
Sanofi
drug pricing
Pieris begins gastric cancer combination trial with Lilly’s Cyramza
Pharmaforum
Tue, 08/11/20 - 11:41 am
Pieris
Eli Lilly
PRS-343
Cyramza
gastric cancer
clinical trial

Pages